DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 100 filers reported holding DESIGN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,086,523 | -62.5% | 460,391 | 0.0% | 0.03% | -58.0% |
| Q2 2023 | $2,900,463 | +9.2% | 460,391 | 0.0% | 0.07% | +9.5% |
| Q1 2023 | $2,656,456 | -43.8% | 460,391 | 0.0% | 0.06% | -44.7% |
| Q4 2022 | $4,723,612 | -38.6% | 460,391 | 0.0% | 0.11% | -42.7% |
| Q3 2022 | $7,698,000 | +19.4% | 460,391 | 0.0% | 0.20% | +5.9% |
| Q2 2022 | $6,445,000 | +15.5% | 460,391 | +33.2% | 0.19% | +34.3% |
| Q1 2022 | $5,581,000 | -22.2% | 345,597 | +3.1% | 0.14% | -15.7% |
| Q4 2021 | $7,178,000 | +46.3% | 335,247 | +0.4% | 0.17% | +61.2% |
| Q3 2021 | $4,907,000 | -25.7% | 334,050 | +0.6% | 0.10% | -21.4% |
| Q2 2021 | $6,604,000 | -32.5% | 332,050 | +1.5% | 0.13% | -38.5% |
| Q1 2021 | $9,785,000 | – | 327,250 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $15,402,483 | 7.89% |
| Logos Global Management LP | 5,032,501 | $11,876,702 | 1.58% |
| Prosight Management, LP | 1,203,745 | $2,840,838 | 0.90% |
| TANG CAPITAL MANAGEMENT LLC | 1,350,000 | $3,186,000 | 0.45% |
| Soleus Capital Management, L.P. | 1,025,000 | $2,419,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,512,986 | $5,930,647 | 0.12% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 180,000 | $425,000 | 0.09% |
| Corton Capital Inc. | 27,134 | $64,036 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,722 | $237,704 | 0.03% |
| Rock Springs Capital Management LP | 460,391 | $1,086,523 | 0.03% |